Pacira Pharmaceuticals (PCRX) Earnings
|
Expand Research on PCRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +2.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/22 | Q222 | N/A | $0.84 | N/A | N/A | $174.26M | N/A | N/A | N/A | ||
| 5/4/22 |  |
Q122 | $0.64 | $0.83 | -$0.19 | $158M | $159.34M | N/A |  | | Details |
| 2/24/22 | |
Q421 | $0.99 | $0.90 | +$0.09 | $159.2M | $155.74M | N/A | | | Details |
| 11/3/21 | |
Q321 | $0.72 | $0.65 | +$0.07 | $127.7M | $130.38M | N/A | | | Details |
| 8/3/21 | |
Q221 | $0.77 | $0.69 | +$0.08 | $135.6M | $128.01M | N/A | | | Details |
| 5/4/21 | |
Q121 | $0.56 | $0.63 | -$0.07 | $119M | $119.28M | N/A | | | Details |
| 2/25/21 | |
Q420 | $0.89 | $0.81 | +$0.08 | $131M | $131.57M | N/A | | | Details |
| 10/29/20 | |
Q320 | $0.68 | $0.61 | +$0.07 | $117.5M | $115.15M | N/A | | | Details |
